The top target differentiating the Aldh1l2 KO group from the WT/Aldh1l1 KO group is interferon gamma, which would be in agreement with recent findings that interferon signaling is responsive to folate status in murine mammary cancer cells [29]. This evidence concerns the gene ALDH1L2 and breast cancer.